Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.97 -0.63 (-1.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Total Liabilities (2011 - 2026)

Updated

Supernus Pharmaceuticals (SUPN) recorded Total Liabilities of $396.88 million in Q2 2026, up 24.6% from $318.51 million a year earlier but down 6.4% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Total Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals reported Total Liabilities of $390.93 million, up 17.6% from FY2024.

  • Annual Total Liabilities has a five-year compound annual growth rate of -12.4% (FY2020 to FY2025).
  • Across earlier years, Total Liabilities came in at $332.34 million in FY2024 (-6.7%), $356.16 million in FY2023 (-56.4%), $816.3 million in FY2022 (-6.5%) and $873.3 million in FY2021 (+15.0%).
  • Quarterly Total Liabilities has ranged from $316.59 million in Q1 2025 to $879.66 million in Q1 2023 over the past five years.
  • On a year-over-year basis, Total Liabilities has increased for four consecutive quarters, with growth averaging 5.4% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 33.9% in Q1 2026, against a decline of 57.4% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $423.92 million (Q1 2026), $390.93 million (Q4 2025) and $370.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Supernus Pharmaceuticals 2.59 Bn 1.25 Bn 185.39 Mn 396.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 396.88 Mn
Mar 31, 2026 423.92 Mn
Dec 31, 2025 390.93 Mn
Sep 30, 2025 370.09 Mn
Jun 30, 2025 318.51 Mn
Mar 31, 2025 316.59 Mn
Dec 31, 2024 332.34 Mn
Sep 30, 2024 335.55 Mn
Jun 30, 2024 358.38 Mn
Mar 31, 2024 374.92 Mn
Dec 31, 2023 356.16 Mn
Sep 30, 2023 372.97 Mn
Jun 30, 2023 373.19 Mn
Mar 31, 2023 879.66 Mn
Dec 31, 2022 816.30 Mn
Sep 30, 2022 840.33 Mn
Jun 30, 2022 853.54 Mn
Mar 31, 2022 811.07 Mn
Dec 31, 2021 873.30 Mn
Sep 30, 2021 744.57 Mn
API Access

Supernus Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=SUPN&period=max&api_key=YOUR_API_KEY